Hypothalamic-Pituitary-Testicular Axis Disruptions in Older Men Are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Context: The cause of declining testosterone (T) in aging men and their relationships with risk factors are unclear. Objective: The objective of the study was to investigate the relationships between lifestyle and health with reproductive hormones in aging men. Design: This was a baseline cross-sectional survey on 3200 community-dwelling men aged 40–79 yr from a prospective cohort study in eight European countries. Results: Four predictors were associated with distinct modes of altered function: 1) age: lower free T (FT; −3.12 pmol/liter·yr, P < 0.001) with raised LH, suggesting impaired testicular function; 2) obesity: lower total T (TT; −2.32 nmol/liter) and FT (−17.60 pmol/liter) for body mass index (BMI; ≥ 25 to < 30 kg/m2) and lower TT (−5.09 nmol/liter) and FT (−53.72 pmol/liter) for BMI 30 kg/m2 or greater (P < 0.001–0.01, referent: BMI < 25 kg/m2) with unchanged/decreased LH, indicating hypothalamus/pituitary dysfunction; 3) comorbidity: lower TT (−0.80 nmol/liter, P < 0.01) with unchanged LH in younger men but higher LH in older men; and 4) smoking: higher SHBG (5.96 nmol/liter, P < 0.001) and LH (0.77 U/liter, P < 0.01) with increased TT (1.31 nmol/liter, P < 0.001) but not FT, compatible with a resetting of T-LH-negative feedback due to elevated SHBG. Conclusions: Complex multiple alterations in the hypothalamic-pituitary-testicular axis function exist in aging men against a background of progressive age-related testicular impairment. These changes are differentially linked to specific risk factors. Some risk factors operate independently of but others interact with age, in contributing to the T decline. These potentially modifiable risk factors suggest possible preventative measures to maintain T during aging in men.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is known that obesity in men is associated with low testosterone and reduced sex hormone-binding globulin (SHBG) levels (19,20,21,22,23).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [23]
In the citing paper
“An obesityassociated decline in SHBG might partially explain the observed fall in testosterone levels (19,20,21,22,23).”
From Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis (2013) · cites this paper as [23]
In the citing paper
“Indeed, epidemiological data suggest that the single most powerful predictor of low testosterone is obesity, and that obesity is a major contributor of the age-associated decline in testosterone levels.16”
From Lowered testosterone in male obesity: Mechanisms, morbidity and management (2014) · cites this paper as [16]
In the citing paper
“Both total testosterone (5.9 nmol l−1) and free testosterone (54 pmol l−1) levels were lower in obese compared to lean men, with lesser but still significant reduction in overweight men (total T 2.3 nmol l−1, free T 18 pmol l−1)16.”
From Lowered testosterone in male obesity: Mechanisms, morbidity and management (2014) · cites this paper as [16]
In the citing paper
“Notably, one study reported cases of males with acquired hypogonadotropic hypogonadism remaining fertile after T treatment (99).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [99]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824 · cited 1×
“Free T levels were derived from total T, SHBG, and albumin concentrations ( 10 ).”
MethodObesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225 · cited 1×
“Although SHBG was negatively associated with increasing strata of obesity, the positive relationship with age was well preserved in obese as well as in the nonobese men, clearly demonstrating the concurrent but opposite (and separate) effects of obesityandageonSHBG(27).Obesityisassociatedwithinsulin resistance ( 28 ),…”
BackgroundBroken Limits to Life Expectancy
Oeppen, J., & Vaupel, J. W. (2002) · Science · doi:10.1126/science.1069675 · Cited by 2,819
Glinoer, D. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0300 · Cited by 1,364 · cited 1×
“Our findings suggest that the apparent increase in total T in smokers occurs through a primary increase in SHBG with a compensatory rise in LH. After this resetting of the “gonadostat,” smokers’ free T remained unchanged.Thissituationisthesameasthe responseofthepituitary-thyroidaxistoincreased thyroid-binding globulin…”
BackgroundGRAY, A., FELDMAN, H. A., MCKINLAY, J. B., & LONGCOPE, C. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-5-1016 · Cited by 1,118
The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications
Kaufman, J. M., & Vermeulen, A. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0013 · Cited by 1,079
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2847 · Cited by 965
The Free Hormone Hypothesis: A Physiologically Based Mathematical Model*
MENDEL, C. M. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-3-232 · Cited by 961
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865 · cited 1×
“Obesity is associated with peripheral and central insulin resistance (30) and proinflammatory cytokine production (TNF and IL-6) from adipocytes (31) and central nervous system endocannibinoid release ( 32 ), all of which are potential candidates for abrogating hypothalamic endocrine and downstream reproductive axis f…”
Backgroundvan den Beld, A. W. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3276 · Cited by 622 · cited 1×
“The present study confirms the age-related cross-sectional trendsincirculatingTincommunity-dwellingmen(6).Themagnitude of fall in total T is modest (0.4% per annum); this is similartosome(16, 17 )butlessthanthatofothercross-sectional studies typically reporting a 0.4–2% annual decline (18–20).”
ResultInfluential
Cited by
Items 101–200 of 938
Testosterone and ill-health in aging men
Yeap, B. B. (2009) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet1050 · Cited by 119
“Prevention of age-related androgen deficiency Several experts have proposed that some risk factors associated with low testosterone levels might operate independently, whereas others interact with aging”
BackgroundWhy Is Androgen Replacement in Males Controversial?
Cunningham, G. R., & Toma, S. M. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0266 · Cited by 111
Testosterone and Prostate Cancer: Revisiting Old Paradigms
Isbarn, H., Pinthus, J. H., Marks, L. S., Montorsi, F., Morales, Á., Morgentaler, A., & Schulman, C. (2009) · European Urology · doi:10.1016/j.eururo.2009.03.088 · Cited by 123
“The recent European Association of Urology (EAU) guidelines state that TT may be considered in symptomatic hypogonadal men who were successfully treated for PCa, after a prudent interval revealing neither clinical nor laboratory evidence of recurrent disease [9].”
Traish, A. M., Feeley, R. J., & Guay, A. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07305.x · Cited by 110
Giagulli, V. A., Carbone, M. D., Ramunni, M. I., Licchelli, B., De Pergola, G., Sabbà, C., Guastamacchia, E., & Triggiani, V. (2015) · Andrology · doi:10.1111/andr.12099 · Cited by 109
“Indeed, by means of different mechanisms, these conditions have both a negative effect on the hypothalamic–pituitary–testicular axis, leading to a reduction in serum T (Giagulli et al., 1994; Wu et al., 2008).”
BackgroundHow to define hypogonadism? Results from a population of men consulting for sexual dysfunction
Rastrelli, G., Corona, G., Tarocchi, M., Mannucci, E., & Maggi, M. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-015-0425-1 · Cited by 109
Fundamental Concepts Regarding Testosterone Deficiency and Treatment
Morgentaler, A., Zitzmann, M., Traish, A. M., Fox, A. W., Jones, T. H., Maggi, M., Arver, S., Aversa, A., Chan, J. C. N., Dobs, A. S., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.007 · Cited by 118
Testosterone deficiency in the aging male
McBride, J. A., Carson, C. C., & Coward, R. M. (2016) · Therapeutic Advances in Urology · doi:10.1177/1756287215612961 · Cited by 106
“4–2% annually after age 30 years [Harman et al. 2001; Kaufman and Vermeulen, 2005; Wu et al. 2008], with 35% of men in the seventh decade having lower testosterone levels than younger men [Vermeulen and Kaufman, 1995], and 13% of older age men meeting diagnostic levels for hypogonadism [Araujo et al.”
BackgroundThe quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism
Mohamed, O., Freundlich, R. E., Dakik, H. K., Grober, E. D., Najari, B., Lipshultz, L. I., & Khera, M. (2010) · International Journal of Impotence Research · doi:10.1038/ijir.2009.35 · Cited by 103
Late‐onset hypogonadism: a concept comes of age
Nieschlag, E. (2020) · Andrology · doi:10.1111/andr.12719 · Cited by 104
The role of testosterone in male sexual function
Corona, G., & Maggi, M. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09748-3 · Cited by 110
Morales, Á., Black, A. M., & Emerson, L. E. (2008) · British Journal of Urology · doi:10.1111/j.1464-410x.2008.07882.x · Cited by 102
Treatment of Men with Central Hypogonadism: Alternatives for Testosterone Replacement Therapy
Ide, V., Vanderschueren, D., & Antonio, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010021 · Cited by 101
“This clinical syndrome is associated with obesity, metabolic syndrome and chronic diseases [12,13].”
BackgroundSelf-citationEriksson, J., Haring, R., Grarup, N., Vandenput, L., Wallaschofski, H., Lorentzen, E., Hansen, T., Mellström, D., Pedersen, O., Nauck, M., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0176277 · Cited by 101
“47 ng/ml lower serum T compared with normal weight subjects (BMI < 25 kg/m(2); [1]).”
BackgroundEffects of liraglutide on obesity-associated functional hypogonadism in men
Jensterle, M., Podbregar, A., Goricar, K., Gregoric, N., & Janez, A. (2019) · Endocrine Connections · doi:10.1530/ec-18-0514 · Cited by 101
Risks and Benefits of Late Onset Hypogonadism Treatment: An Expert Opinion
Corona, G., Vignozzi, L., Sforza, A., & Maggi, M. (2013) · The World Journal of Men s Health · doi:10.5534/wjmh.2013.31.2.103 · Cited by 104
Rosenfield, R. L., & Bordini, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.088 · Cited by 103
“Obesity has become recognized as a cause of hypoandrogenism in men (Kaufman and Vermeulen, 2005; MacDonald et al., 2010; Vermeulen, 1993; Wu et al., 2008).”
BackgroundHaring, R., Ittermann, T., Völzke, H., Krebs, A., Zygmunt, M., Felix, S. B., Grabe, H. J., Nauck, M., & Wallaschofski, H. (2010) · The Aging Male · doi:10.3109/13685538.2010.487553 · Cited by 100
“This finding is in line with previously discussed implications, suggesting the age-related and potentially preventable and/or reversible decline in TT as a barometer of health [38].”
BackgroundResultInfluentialAndrogen Deficiency Exacerbates High-Fat Diet-Induced Metabolic Alterations in Male Mice
Dubois, V., Laurent, M. R., Jardi, F., Antonio, L., Lemaire, K., Goyvaerts, L., Deldicque, L., Carmeliet, G., Decallonne, B., Vanderschueren, D., et al. (2016) · Endocrinology · doi:10.1210/en.2015-1713 · Cited by 100
Self-citationTesticular Aging: An Overview of Ultrastructural, Cellular, and Molecular Alterations
Santiago, J., Silva, J. V., Alves, M. G., Oliveira, P. F., & Fardilha, M. (2018) · The Journals of Gerontology Series A · doi:10.1093/gerona/gly082 · Cited by 106
Khera, M., Broderick, G. A., Carson, C. C., Dobs, A. S., Faraday, M. M., Goldstein, I., Hakim, L. S., Hellstrom, W. J. G., Kacker, R., Köhler, T. S., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.04.022 · Cited by 96
Narinx, N., David, K., Walravens, J., Vermeersch, P., Claessens, F., Fiers, T., Lapauw, B., Antonio, L., & Vanderschueren, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04562-1 · Cited by 96
“Indeed, the European Male Aging Study (EMAS) showed different cross-sectional age trends concerning SHBG and androgen status in community-dwelling men aged 40–79 years [61].”
BackgroundSelf-citationTestosterone replacement therapy: for whom, when and how?
Tsametis, C. P., & Isidori, A. M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.007 · Cited by 96
Cunningham, G. R., Stephens-Shields, A. J., Rosen, R. C., Wang, C., Ellenberg, S. S., Matsumoto, A. M., Bhasin, S., Molitch, M. E., Farrar, J. T., Cella, D., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3818 · Cited by 95
Why does COVID‐19 kill more elderly men than women? Is there a role for testosterone?
Papadopoulos, V., Li, L., & Samplaski, M. K. (2020) · Andrology · doi:10.1111/andr.12868 · Cited by 104
“4% to 2% per year starting at around age 30 and can result in low levels of serum T, termed “hypogonadism”, at advanced ages (15-17).”
BackgroundDudek, M., Kolodziejski, P. A., Pruszyńska‐Oszmałek, E., Sassek, M., Ziarniak, K., Nowak, K. W., & Sliwowska, J. H. (2016) · Neuropeptides · doi:10.1016/j.npep.2016.01.005 · Cited by 107
Adverse effects of testosterone replacement therapy: an update on the evidence and controversy
Grech, A., Breck, J., & Heidelbaugh, J. (2014) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098614548680 · Cited by 91
The treatment of hypogonadism in men of reproductive age
Kim, E. D., Crosnoe, L., Bar-Chama, N., Khera, M., & Lipshultz, L. I. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.10.052 · Cited by 89
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia
Alfano, M., Tascini, A. S., Pederzoli, F., Locatelli, I., Nebuloni, M., Giannese, F., García-Manteiga, J. M., Tonon, G., Amodio, G., Gregori, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25544-0 · Cited by 101
Obesity and the reproductive system disorders: epigenetics as a potential bridge
Crujeiras, A. B., & Casanueva, F. F. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu060 · Cited by 89
“This potential effect of obesity on the hypothalamic–pituitary–testicular axis can be dissociated from those of age; whereas the reductions in testosterone that are observed with obesity are concomitant with unchanged or even reduced LH in obese older men, age is associated with a compensatory increase in the LH, whic…”
BackgroundInfluentialSelf-citationMale late-onset hypogonadism: pathogenesis, diagnosis and treatment
Huhtaniemi, I., & Forti, G. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.47 · Cited by 88
“The concentration of serum testosterone starts steadily declining at ∼30–40 years of age at a rate of about 1% per year ( Figure 1a )”
BackgroundSelf-citationNeuroanatomy of the Human Hypothalamic Kisspeptin System
Hrabovszky, E. (2014) · Neuroendocrinology · doi:10.1159/000356903 · Cited by 89
Why men age faster but reproduce longer than women: mTOR and evolutionary perspectives
Blagosklonny, M. V. (2010) · Aging · doi:10.18632/aging.100149 · Cited by 88
“There is a gradual decrease in fertility in men too (analogous to pre-menopause), although this usually does not result in testicular failure during a man’s lifetime [57, 58].”
A UK epidemic of testosterone prescribing, 2001–2010
Gan, E. H., Pattman, S., Pearce, S. H. S., & Quinton, R. (2013) · Clinical Endocrinology · doi:10.1111/cen.12178 · Cited by 92
Testosterone therapy increased muscle mass and lipid oxidation in aging men
Frederiksen, L., Højlund, K., HOUGAARD, D. M., Brixen, K., & Andersen, M. (2011) · AGE · doi:10.1007/s11357-011-9213-9 · Cited by 94
“We chose bioavailable testosterone as SHBG is known to increase with age (Wu et al. 2008).”
MethodBauer, J. M., Cruz-Jentoft, A. J., Fielding, R. A., Kanis, J. A., Reginster, J.-Y., Bruyère, O., Cesari, M., Chapurlat, R., Al-Daghri, N., Dennison, E., et al. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00561-w · Cited by 83
The prevalence of and risk factors for androgen deficiency in aging Taiwanese men
Liu, C.-C., Wu, W.-J., Lee, Y.-C., Wang, C.-J., Ke, H.-L., Li, W.-M., Hsiao, H.-L., Yeh, H.-C., Li, C.-C., Chou, Y.-H., et al. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01171.x · Cited by 82
Lotti, F., Corona, G., Vitale, P., Maseroli, E., Rossi, M., Fino, M. G., & Maggi, M. (2015) · Human Reproduction · doi:10.1093/humrep/deu347 · Cited by 79
“…levels between CS and PS retained significance even after adjusting for confounding factors, including age and BMI, which play an independent and crucial role in the control of testosterone plasma levels (Laaksonen et al., 2005; Wu et al., 2008; Tajar et al., 2010; Corona et al., 2013).”
BackgroundResultInfluentialThe impact of obesity on male fertility
Chambers, T. J. G., & Anderson, R. A. (2015) · HORMONES · doi:10.14310/horm.2002.1621 · Cited by 101
Saad, F., & Gooren, L. J. (2011) · Journal of Obesity · doi:10.1155/2011/471584 · Cited by 82
Off-label use of hormones as an antiaging strategy: a review
Samaras, N., Papadopoulou, M.-A., Samaras, D., & Ongaro, F. (2014) · Clinical Interventions in Aging · doi:10.2147/cia.s48918 · Cited by 93
“52 This results in a 20% and 30%–50% prevalence of low total T levels in men aged 60 years and 80 years, respectively.”
Cigarette smoking has a positive and independent effect on testosterone levels
Wang, W., Yang, X., Liang, J., Liao, M., Zhang, H., Qin, X., Mo, L., Lv, W., & Mo, Z. (2013) · Hormones · doi:10.14310/horm.2002.1445 · Cited by 79
“On the other hand, several other studies have demonstrated higher SHBG levels in smokers.(28,31,40) Since SHBG levels can be affected by a variety of conditions, the association seen in previous studies(14,28,31) may be due to potential confounders, such as alcohol consumption and estradiol levels, which were adjusted…”
Kaminetsky, J., Werner, M., Fontenot, G., & Wiehle, R. D. (2013) · The Journal of Sexual Medicine · doi:10.1111/jsm.12116 · Cited by 78
Hopmans, S., Duivenvoorden, W., Werstuck, G. H., Klotz, L. H., & Pinthus, J. H. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.06.018 · Cited by 86
Testosterone therapy, thrombosis, thrombophilia, cardiovascular events
Glueck, C. J., & Wang, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.05.005 · Cited by 84
“As emphasized by Layton et al [7], testosterone (T) levels fall with increasing age [8], with chronic disease [9, 10] , and with obesity [9], but smoking has been associated with higher T [11, 12].”
BackgroundSex differences in 11-oxygenated androgen patterns across adulthood
Davio, A., Woolcock, H., Nanba, A. T., Rege, J., O’Day, P., Ren, J., Zhao, L., Ebina, H., Auchus, R., Rainey, W. E., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa343 · Cited by 76
Giannetta, E., Gianfrilli, D., Barbagallo, F., Isidori, A. M., & Lenzi, A. (2012) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.12.005 · Cited by 79
Testosterone Therapy: What We Have Learned From Trials
Corona, G., Torres, L. O., & Maggi, M. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.11.270 · Cited by 81
Are declining testosterone levels a major risk factor for ill-health in aging men?
Yeap, B. B. (2008) · International Journal of Impotence Research · doi:10.1038/ijir.2008.60 · Cited by 81
Hernandez, P., Passi, N., Modarressi, T., Kulkarni, V., Soni, M., Burke, F., Bajaj, A., & Soffer, D. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00962-z · Cited by 71
Basaria, S. S. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.012 · Cited by 82
The practical management of testosterone deficiency in men
Aversa, A., & Morgentaler, A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.238 · Cited by 78
Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction
Podlasek, C. A., Mulhall, J. P., Davies, K. P., Wingard, C. J., Hannan, J. L., Bivalacqua, T. J., Musicki, B., Khera, M., González-Cadavid, N. F., & Burnett, A. L. “. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.06.004 · Cited by 76
Golan, R., Scovell, J. M., & Ramasamy, R. (2015) · The Aging Male · doi:10.3109/13685538.2015.1052392 · Cited by 73
Exogenous testosterone: a preventable cause of male infertility.
Crosnoe-Shipley, L., Grober, E. D., Ohl, D. A., & Kim, E. D. (2013) · PubMed Central · doi:10.3978/j.issn.2223-4683.2013.06.01 · Cited by 92
Yu, I.-C., Lin, H.-Y., Sparks, J. D., Yeh, S., & Chang, C. (2014) · Diabetes · doi:10.2337/db13-1505 · Cited by 70
Fiers, T., Wu, F., Moghetti, P., Vanderschueren, D., Lapauw, B., & Kaufman, J.-M. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02360 · Cited by 70
Self-citationHaider, A., Saad, F., Doros, G. D., & Gooren, L. J. (2013) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2013.10.005 · Cited by 76
“More detailed analysis has shown that calendar age per se may be a factor but obesity is a major determinant in the decline of serum testosterone at all ages [8,9].”
BackgroundHypogonadism as a possible link between metabolic diseases and erectile dysfunction in aging men
Corona, G., Bianchini, S., Sforza, A., Vignozzi, L., & Maggi, M. (2015) · HORMONES · doi:10.14310/horm.2002.1635 · Cited by 74
Rastrelli, G., O'Neill, T. W., Ahern, T., Bártfai, G., Casanueva, F. F., Forti, G., Keevil, B., Giwercman, A., Han, T. S., Slowikowska‐Hilczer, J., et al. (2018) · Clinical Endocrinology · doi:10.1111/cen.13756 · Cited by 69
Self-citationBenefits and Risks of Testosterone Treatment in Men with Age-Related Decline in Testosterone
dos Santos, M. R., & Bhasin, S. (2020) · Annual Review of Medicine · doi:10.1146/annurev-med-050219-034711 · Cited by 78
Pencina, K. M., Travison, T. G., Artz, A. S., Lincoff, A. M., Nissen, S. E., Flevaris, P., Chan, A., Li, X., Diegel, S. A., Wannemuehler, K. A., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.40030 · Cited by 82
Hypogonadism in chronic obstructive pulmonary disease: incidence and effects
Balasubramanian, V. P., & Naing, S. (2012) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32834feb37 · Cited by 73
Tatem, A. J., Beilan, J., Kovac, J. R., & Lipshultz, L. I. (2020) · The World Journal of Men's Health · doi:10.5534/wjmh.190002 · Cited by 66
“There is an age-related decline in total serum testosterone values, resulting in an increased incidence of hypogonadism in the aging population [30].”
BackgroundOpioid-Induced Hypogonadism: Why and How to Treat It
Aloisi, A. M. (2012) · Pain Physician · doi:10.36076/ppj.2012/15/es111 · Cited by 54
Evaluation of the effects of cigarette smoking on testosterone levels in adult men
Halmenschlager, G., Rossetto, S., Lara, G. M., & Rhoden, E. L. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01227.x · Cited by 65
Age-related changes in human Leydig cell status
Mularoni, V., Esposito, V., Di Persio, S., Vicini, E., Spadetta, G., Berloco, P., Fanelli, F., Mezzullo, M., Pagotto, U., Pelusi, C., et al. (2020) · Human Reproduction · doi:10.1093/humrep/deaa271 · Cited by 67
Recommendations on the diagnosis, treatment and monitoring of testosterone deficiency in men
Lunenfeld, B., Mskhalaya, G. J., Zitzmann, M., Corona, G., Arver, S., Kalinchenko, S. Y., Tishova, Y. A., & Morgentaler, A. (2021) · The Aging Male · doi:10.1080/13685538.2021.1962840 · Cited by 68
Male hypogonadism: pathogenesis, diagnosis, and management
de Silva, N. L., Papanikolaou, N., Grossmann, M., Antonio, L., Quinton, R., Anawalt, B. D., & Jayasena, C. N. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00199-2 · Cited by 78
A cohort effect on serum testosterone levels in Finnish men
Perheentupa, A., Mäkinen, J., Laatikainen, T., Vierula, M., Skakkebaek, N. E., Andersson, A.-M., & Toppari, J. (2013) · European Journal of Endocrinology · doi:10.1530/eje-12-0288 · Cited by 64
Various Factors May Modulate the Effect of Exercise on Testosterone Levels in Men
Riachy, R., McKinney, K., & Tuvdendorj, D. (2020) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk5040081 · Cited by 66
“The underlying mechanisms of this relation include: (a) attenuated amplitude of LH pulses due to obesity-induced systemic inflammation [60]; (b) increased aromatization of circulating testosterone in the adipose tissue [61]; and (c) higher leptin production by fat cells which has been shown to disrupt testosterone pro…”
BackgroundThe complex association between metabolic syndrome and male hypogonadism
Dimopoulou, C., Goulis, D. G., Corona, G., & Maggi, M. (2018) · Metabolism · doi:10.1016/j.metabol.2018.03.024 · Cited by 70
Age-related testosterone decline: mechanisms and intervention strategies
Cheng, H., Zhang, X., Li, Y., Cao, D., Luo, C., Zhang, Q., Zhang, S., & Jiao, Y. (2024) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-024-01316-5 · Cited by 77
Ip, F. F., di Pierro, I., Brown, R., Cunningham, I., Handelsman, D. J., & Liu, P. Y. (2010) · European Journal of Endocrinology · doi:10.1530/eje-09-0717 · Cited by 59
Late-Life Onset Hypogonadism: A Review
Bassil, N., & Morley, J. E. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.02.003 · Cited by 59
“This decline of testosterone levels in aging men may result from reduced testicular responses to gonadotrophin stimuli with aging, coupled with incomplete hypothalamo-pituitary compensation for the decrease in total and free testosterone levels.(15,16)”
Practical Use of Pharmacotherapy for Obesity
Igel, L. I., Kumar, R. B., Saunders, K. H., & Aronne, L. J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.12.049 · Cited by 62
Khripun, I., Vorobyev, S., Белоусов, И. И., Коган, М. И., & Zitzmann, M. (2018) · The Aging Male · doi:10.1080/13685538.2018.1506918 · Cited by 65
“In men, serum testosterone (T) levels decrease about 1% per year after the third decade of life [1].”
BackgroundTestosterone Deficiency and Peyronie’s Disease: Pilot Data Suggesting a Significant Relationship
Moreno, S. A., & Morgentaler, A. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2009.01250.x · Cited by 57
Grandys, M., Majerczak, J., Zapart-Bukowska, J., Duda, K., Kulpa, J., & Zoladz, J. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.735638 · Cited by 60
Bisphenol A analogues in associations with serum hormone levels among reproductive-aged Chinese men
Zeng, J.-Y., Chen, P., Liu, C., Deng, Y.-L., Yu, M., Zhang, M., Cui, F., Lu, T., Shi, T., Yang, K., et al. (2022) · Environment International · doi:10.1016/j.envint.2022.107446 · Cited by 58
Traish, A. M., & Zitzmann, M. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-015-9323-2 · Cited by 60
“Yassin and Doros [61]▪▪ Injectable TU 12–60 months ↓ ↓ ↓”
BackgroundInfluentialPredicting low testosterone in aging men: a systematic review
Millar, A. C., Lau, A. N. C., TOMLINSON, G. A., Kraguljac, A. P., Simel, D. L., Detsky, A. S., & Lipscombe, L. L. (2016) · Canadian Medical Association Journal · doi:10.1503/cmaj.150262 · Cited by 67
Testosterone boosts physical activity in male mice via dopaminergic pathways
Jardí, F., Laurent, M. R., Kim, N., Khalil, R., De Bundel, D., Van Eeckhaut, A., Van Helleputte, L., Deboel, L., Dubois, V., Schollaert, D., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-19104-0 · Cited by 55
Self-citationAn Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
Agrawal, H., Das, N., Nathani, S., Saha, S., Saini, S. K., Kakar, S. S., & Roy, P. (2020) · Stem Cell Reviews and Reports · doi:10.1007/s12015-020-10048-z · Cited by 65
Emerging concepts on Leydig cell development in fetal and adult testis
Bhattacharya, I., & Dey, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1086276 · Cited by 59
Rotter, I., Kosik-Bogacka, D. I., Dołęgowska, B., Safranow, K., Kuczyńska, M., & Laszczyńska, M. (2015) · Environmental Geochemistry and Health · doi:10.1007/s10653-015-9758-0 · Cited by 60
Correlates of low testosterone in men with chronic spinal cord injury
Barbonetti, A., Vassallo, M. R. C., Pacca, F., Cavallo, F., Costanzo, M., Felzani, G., Francavilla, S., & Francavilla, F. (2014) · Andrology · doi:10.1111/j.2047-2927.2014.00235.x · Cited by 60
“…fall in association with many coexisting factors (accumulating comorbidities, medication use, obesity), and they change in response to changing health status (Travison et al., 2007; Wu et al., 2008; Yeap, 2009), serum testosterone could be considered a biomarker of good health (McLachlan, 2010).”
BackgroundTestosterone deficiency in adults and corresponding treatment patterns across the globe
Anaissie, J. E., DeLay, K. J., Wang, W., Hatzichristodoulou, G., & Hellstrom, W. J. G. (2017) · Translational Andrology and Urology · doi:10.21037/tau.2016.11.16 · Cited by 58
“Specifically, TD coincides with the presence of comorbidities, reaching as high as 80% in patients with multiple comorbidities (5-9).”
BackgroundLow Testosterone in Adolescents & Young Adults
Cohen, J. A., Nassau, D. E., Patel, P., & Ramasamy, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00916 · Cited by 68
“According to the European Male Aging Study at least three clinical sexual symptoms should be present in conjunction with the laboratory abnormal values to confirm the diagnosis of androgen deficiency (8).”
BackgroundWestley, C. J., AMDUR, R. L., & Irwig, M. S. (2015) · The Journal of Sexual Medicine · doi:10.1111/jsm.12937 · Cited by 62
Rohrmann, S., Platz, E. A., Selvin, E., Shiels, M. S., Joshu, C. E., Menke, A., Feinleib, M., Basaria, S. S., Rifai, N., Dobs, A. S., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04043.x · Cited by 57
Evaluation of Sex Differences in Preclinical Pharmacology Research: How Far Is Left to Go?
Allegra, S., Chiara, F., Grazia, D. D., Gaspari, M., & Francia, S. D. (2023) · Pharmaceuticals · doi:10.3390/ph16060786 · Cited by 57
An overview on androgen-mediated actions in skeletal muscle and adipose tissue
Rizk, J. G., Sahu, R., & Duteil, D. (2023) · Steroids · doi:10.1016/j.steroids.2023.109306 · Cited by 65
Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.
Cattabiani, C., Basaria, S. S., Ceda, G. P., Luci, M., Vignali, A., Lauretani, F., Valenti, G., Volpi, R., & Maggio, M. G. (2012) · PubMed · doi:10.3275/8061 · Cited by 58
“found an association between progressively lower total and free T and increasing BMI, obesity and other comorbidities, independently of SHBG levels (29).”
BackgroundAndrogen Physiology, Pharmacology, and Abuse
Handelsman, D. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00138-4 · Cited by 66
Xia, F., Xu, X., Zhai, H., Meng, Y., Zhang, H., Du, S., Xu, H., Wu, H., & Lu, Y. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-106 · Cited by 54
“Background Late-onset hypogonadism (LOH) or age-associated testosterone deficiency syndrome, which is defined as a clinical and biochemical syndrome associated with advancing age and is characterized by symptoms of hypogonadism and a deficiency in serum testosterone levels, has become a world-wide concern because it a…”
BackgroundCorona, G., Rastrelli, G., Monami, M., Melani, C., Balzi, D., Sforza, A., Forti, G., Mannucci, E., & Maggi, M. (2011) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2011.02292.x · Cited by 51
Self-citationAdverse health effects of testosterone deficiency (TD) in men
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.010 · Cited by 53
Kumagai, H., Yoshikawa, T., Zempo-Miyaki, A., Myoenzono, K., Tsujimoto, T., Tanaka, K., & Maeda, S. (2018) · Hormone and Metabolic Research · doi:10.1055/s-0043-117497 · Cited by 51
Kirby, M., Hackett, G. I., & Ramachandran, S. (2019) · European Cardiology Review · doi:10.15420/ecr.2019.13.1 · Cited by 55
“Additional causes of TD include obesity, diabetes, metabolic syndrome, HIV infection, chronic renal failure, and chronic glucocorticoid and opioid use.(19,20)”
Background
Metadata
- Authors
- Wu, F. C. W., Tajar, A., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F., Forti, G., Giwercman, A., Huhtaniemi, I. T., Kula, K., Punab, M., Boonen, S., Vanderschueren, D., & The European Male Aging Study Group
- Affiliations
- Manchester Royal Infirmary (GB)
- University of Manchester (GB)
- Department of ARC Epidemiology Unit (A.T., S.R.P., A.J.S., J.D.F., T.W.O.), The University of Manchester, Manchester M13 9PT, United Kingdom
- Department of Obstetrics, Gynaecology, and Andrology (G.B.), Albert Svent-Gyorgy Medical University, Szeged 6725, Hungary
- Universidade de Santiago de Compostela (ES)
- University of Florence (IT)
- Lund University (SE)
- Imperial College London (GB)
- Medical University of Lodz (PL)
- Tartu University Hospital (EE)
- KU Leuven (BE)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-07-01
- Volume
- 93
- Issue
- 7
- Pages
- 2737-2745
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2155228880
- Semantic Scholar
- 12ac293cf4312c58f80b9c0104201804e7863c96
- Cited by
- 939
- References
- 41
- Citations by year
- 2026: 35 · 2025: 51 · 2024: 48 · 2023: 52 · 2022: 60 · 2021: 55 · 2020: 67 · 2019: 58 · 2018: 56 · 2017: 48 · 2016: 56 · 2015: 58 · 2014: 59 · 2013: 46 · 2012: 48
- FWCI
- 33.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Health Sciences › Medicine › Reproductive Medicine › Sperm and Testicular Function
- Keywords
- hypothalamic-pituitary-testicular axis, male aging, testosterone decline, free testosterone, luteinizing hormone, obesity, smoking, comorbidities, sex hormone-binding globulin, testicular function, older men
- MeSH terms
- Adult, Aged, Aging, Alcohol Drinking, Cross-Sectional Studies, Humans, Hypothalamo-Hypophyseal System, Luteinizing Hormone, Male, Middle Aged, Obesity, Risk Factors, Sex Hormone-Binding Globulin, Testis, Testosterone, Comorbidity, Body Mass Index, Waist-Hip Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.